#1 Clinical Trials Search in Europe

Lansoprazole

Lansoprazole is a medication used to treat various gastrointestinal disorders, particularly those related to excess stomach acid. This article explores the use of lansoprazole in clinical trials, focusing on its effectiveness in treating conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and other related disorders. We’ll examine the drug’s safety profile, dosage forms, and its comparison with other similar medications.

Table of Contents

What is Lansoprazole?

Lansoprazole is a medication that belongs to a class of drugs called proton pump inhibitors (PPIs). It is commonly used to treat various conditions related to the stomach and esophagus. Lansoprazole is known by several brand names, including Prevacid, Helicid, Zoton, Inhibitol, and Agopton[1]. The medication is also sometimes referred to by its research code, AG-1749[2].

How Does Lansoprazole Work?

Lansoprazole works by reducing the amount of acid produced in your stomach. It does this by blocking a specific enzyme in the stomach lining that is responsible for acid production. By decreasing stomach acid, lansoprazole helps to relieve symptoms caused by excess acid and allows damaged tissues in the esophagus and stomach to heal[1].

Conditions Treated by Lansoprazole

Lansoprazole is used to treat several conditions related to the digestive system, including:

  • Gastroesophageal Reflux Disease (GERD): This is a condition where stomach acid frequently flows back into the esophagus, causing symptoms like heartburn and acid regurgitation[1].
  • Erosive Esophagitis: This is a severe form of GERD where stomach acid has damaged the lining of the esophagus[3].
  • Peptic Ulcers: These are sores that develop on the lining of the stomach or small intestine[1].
  • Zollinger-Ellison Syndrome: This is a rare condition that causes tumors in the pancreas or small intestine, leading to excessive production of stomach acid[1].

Dosage and Administration

Lansoprazole is typically taken orally in the form of capsules. The dosage and duration of treatment can vary depending on the condition being treated and the individual patient’s needs. In clinical trials, common dosages included:

  • 30 mg once daily for up to 8 weeks for treating erosive esophagitis[3].
  • 30 mg once daily for up to 7 days in some studies[2].

It’s important to note that your doctor will prescribe the appropriate dosage for your specific condition. Always follow your healthcare provider’s instructions regarding dosage and duration of treatment.

Effectiveness of Lansoprazole

Clinical studies have shown lansoprazole to be effective in treating various acid-related disorders. For example, in a study comparing lansoprazole to dexlansoprazole (another PPI), both medications were effective in healing erosive esophagitis after 8 weeks of treatment[3]. The effectiveness was measured by examining the esophagus with an endoscope and assessing symptom relief.

Lansoprazole has also been shown to be effective in controlling stomach acid levels. In one study, researchers measured the acid output in the stomach before and after treatment with lansoprazole[2].

Potential Side Effects

Like all medications, lansoprazole can cause side effects, although not everyone experiences them. Some potential side effects may include:

  • Nausea
  • Diarrhea
  • Constipation
  • Headache
  • Dizziness
  • Fatigue
  • Flatulence (gas)[4]

If you experience any persistent or severe side effects, it’s important to contact your healthcare provider.

Comparison with Other Medications

Lansoprazole is one of several proton pump inhibitors available. Other PPIs include dexlansoprazole (also known as Dexilant or Kapidex)[3]. In some studies, researchers have compared the effectiveness of lansoprazole to other PPIs like dexlansoprazole in treating conditions such as erosive esophagitis[3].

Another study compared the effectiveness of lansoprazole to dexlansoprazole in treating atypical symptoms of GERD, such as chronic cough, globus sensation (feeling of a lump in the throat), and non-cardiac chest pain[4]. These studies help doctors understand which medications might be most effective for different patients and conditions.

Long-term Use of Lansoprazole

Some patients may need to take lansoprazole for extended periods. A long-term study followed patients taking lansoprazole for up to five years to assess its safety and effectiveness over time[1]. The study looked at various factors, including:

  • Changes in symptoms over time
  • Effects on the lining of the stomach and esophagus
  • Potential effects on other body systems, such as hormone levels and eye health

If you’re prescribed lansoprazole for long-term use, your doctor will likely monitor you regularly to ensure the medication continues to be safe and effective for you.

Aspect Details
Primary Uses Treatment of GERD, erosive esophagitis, non-cardiac chest pain related to GERD
Dosage Forms Oral capsules, intravenous injection
Typical Dosages 15 mg to 60 mg daily
Main Outcomes Measured Healing of erosive esophagitis, reduction in GERD symptoms, changes in acid output
Comparison Studies Often compared with dexlansoprazole and other proton pump inhibitors
Special Populations Pediatric studies focus on safety, efficacy, and appropriate dosing in children
Safety Considerations Long-term studies assess potential effects on hormone levels, eye health, and gastrointestinal cell changes

FAQ

  • What is lansoprazole used for in clinical trials? Lansoprazole is primarily used in clinical trials to treat conditions related to excess stomach acid, such as gastroesophageal reflux disease (GERD), erosive esophagitis, and non-cardiac chest pain associated with GERD.
  • How is lansoprazole administered in clinical trials? In clinical trials, lansoprazole is typically administered orally as capsules. Some studies have also explored intravenous administration. Dosages range from 15 mg to 60 mg, taken once or twice daily, depending on the condition being treated and the specific trial protocol.
  • What are the main outcomes measured in lansoprazole clinical trials? Clinical trials often measure outcomes such as healing of erosive esophagitis, reduction in GERD symptoms (like heartburn and acid regurgitation), changes in acid output, and overall safety and tolerability of the medication.
  • How does lansoprazole compare to other similar medications in trials? Some trials compare lansoprazole to other proton pump inhibitors like dexlansoprazole. These studies often look at factors such as bioequivalence, efficacy in treating specific conditions, and safety profiles to determine how lansoprazole measures up against other options.
  • Are there any special considerations for lansoprazole use in pediatric patients? Yes, some clinical trials specifically focus on the use of lansoprazole in pediatric patients with GERD. These studies aim to determine appropriate dosing, safety, and efficacy in children of different age groups, as the medication's effects may differ from those in adults.

Ongoing Clinical Trials on Lansoprazole

  • Comparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease

    Recruiting

    3 1 1
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Poland Romania

  • Study on Walking Rehabilitation for Hip or Knee Osteoarthritis Using Ketoprofen and Drug Combination for Patients with Osteoarthritis

    Recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Study on Lansoprazole for Preventing Acid Reflux in Patients with Esophageal Achalasia After Endoscopic Myotomy

    Recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Study of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease

    Not recruiting

    3 1 1
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Poland Romania

Glossary

  • Gastroesophageal Reflux Disease (GERD): A digestive disorder that occurs when stomach acid frequently flows back into the esophagus, causing symptoms such as heartburn and acid regurgitation.
  • Erosive Esophagitis: A condition where the lining of the esophagus becomes inflamed and damaged due to prolonged exposure to stomach acid.
  • Proton Pump Inhibitor (PPI): A class of medications, including lansoprazole, that reduce stomach acid production by blocking the enzyme in the wall of the stomach that produces acid.
  • Endoscopy: A medical procedure that uses a long, thin tube with a camera to examine the inside of the body, often used to assess the severity of esophageal conditions in GERD studies.
  • Bioequivalence: The property of two drug products having the same rate and extent of absorption, used to compare different formulations or brands of the same medication.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Cmax: The maximum concentration of a drug in the blood after administration, used to measure the peak effect of the medication.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, used to assess the overall effectiveness and duration of action of a medication.
  • Tmax: The time it takes for a drug to reach its maximum concentration in the blood after administration.
  • Los Angeles Classification: A system used to grade the severity of erosive esophagitis based on endoscopic findings, ranging from Grade A (least severe) to Grade D (most severe).

References

  1. https://clinicaltrials.gov/study/NCT01135368
  2. https://clinicaltrials.gov/study/NCT00175045
  3. https://clinicaltrials.gov/study/NCT00251719
  4. https://clinicaltrials.gov/study/NCT03418337